Dexmedetomidine for Refractory Pain in Palliative Cancer Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The goal of this study is to find out whether the medication dexmedetomidine can be a safe and effective additional treatment for cancer patients whose pain is not well controlled by standard pain medicines (such as opioids). The study includes 30 palliative care patients who still have significant pain despite standard pain treatment. All participants will receive dexmedetomidine, and outcomes related to efficacy and safety will be systematically observed.
Epistemonikos ID: e0303523fea13252b670c97a281469e0ae801eaa
First added on: Oct 22, 2026